Loading interactive chart...
1DInterval:
Date Range
1 min
This biotech growth stock is climbing its way up a base on its way to a buy point. The company's sales are expected to continue to soar.
Procept BioRobotics and Ascendis Pharma may not show profits but the stocks have outperformed the S&P 500 in 2024. Shares are near buy points.
Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.